Solifenacin 5mg

DRUG6 trials

Sponsors

NICHD Pelvic Floor Disorders Network, Dong-A ST Co., Ltd., Buddhist Tzu Chi General Hospital, University of Naples, Mansoura University

Conditions

Dry AMDOveractive BladderOveractive Bladder (OAB)Overactive Bladder SyndromeUrge Urinary Incontinence

Phase 2

A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder

CompletedNCT03566134

Dong-A ST Co., Ltd.Overactive Bladder

Start: 2018-07-10End: 2019-12-27Updated: 2020-02-07

Comparison of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After TURP

Buddhist Tzu Chi General HospitalOveractive Bladder Syndrome

Start: 2018-08-01End: 2019-07-31Target: 130Updated: 2018-08-24

Phase 3

Anticholinergic vs. Botox Comparison Study

CompletedNCT01166438

NICHD Pelvic Floor Disorders NetworkOveractive Bladder, Urge Urinary Incontinence

Start: 2010-03-31End: 2012-05-31Updated: 2018-05-02

A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder

CompletedNCT05282069

Dong-A ST Co., Ltd.Overactive Bladder

Start: 2022-05-12End: 2024-05-29Updated: 2024-06-26

Phase 4

Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National Study

RecruitingNCT07416968

Mansoura UniversityOveractive Bladder (OAB), Overactive Bladder Syndrome

Start: 2025-09-01End: 2026-12-01Target: 480Updated: 2026-02-18

Unknown Phase

Mirabegron in Patients With Age-Related Macular Degeneration

Not yet recruitingNCT07305298

University of NaplesDry AMD, Overactive Bladder

Start: 2026-04-01End: 2026-12-01Target: 312Updated: 2026-02-06

Related Papers

Mirabegron in patients with age-related macular degeneration treated for overactive bladder: a study protocol for a prospective observational non-randomized trial

Frontiers in Medicine2026-03-16

Complete genome sequences of <i>Aerococcus loyolae</i> ATCC TSD-300 <sup>T</sup> , <i>Aerococcus mictus</i> ATCC TSD-301 <sup>T</sup> , and <i>Aerococcus tenax</i> ATCC TSD-302 <sup>T</sup>

Microbiology Resource Announcements2024-04-232 citations

Efficacy and Safety of DA-8010, a Novel M3 Antagonist, in Patients With Overactive Bladder: A Randomized, Double-Blind Phase 2 Study

International Neurourology Journal2022-06-299 citations

Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence.

2012-10-04143 citations